Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Zhang

Showing results (531-540 of 553) with videos related to

Pageof 56
Sort By:
Gastroenterology|November 4, 2019
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma CellsJunyu Xiang, Ni Zhang, Hui Sun, et al.
Hepatology (Baltimore, Md.)|January 17, 2023
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signalingLiangjun Zhang, Qiong Pan, Lu Zhang, et al.
Nature Immunology|July 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppressionXing Yang, Ryan Huang, Meng Fang, et al.
Hepatology (Baltimore, Md.)|July 10, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylationLiangjun Zhang, Pingfan Xie, Mingqiao Li, et al.
ACS Nano|August 20, 2025
Endogenous Targeting of Lipid Nanoparticles to Kidney TumorsAmogh Vaidya, Yun-Chieh Sung, Vanina Toffessi Tcheuyap, et al.
ACS Nano|December 30, 2022
Mo<sub>2</sub>TiC<sub>2</sub> MXene-Supported Ru Clusters for Efficient Photothermal Reverse Water-Gas ShiftZhiyi Wu, Jiahui Shen, Chaoran Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 RadioligandsDaniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Physical Review Letters|September 27, 2024
Dominant Charge Density Order in TaTe_{4}Hongtao Rong, Qiangqiang Gu, Xue Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA<sup>+</sup> Metastatic Colorectal CancersChengcheng Zhang, Zhe Wang, Zhi Yang, et al.
Pageof 56

Showing results (531-540 of 553) with videos related to

Sort By:
Pageof 56
Gastroenterology|November 4, 2019
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma CellsJunyu Xiang, Ni Zhang, Hui Sun, et al.
Hepatology (Baltimore, Md.)|January 17, 2023
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signalingLiangjun Zhang, Qiong Pan, Lu Zhang, et al.
Nature Immunology|July 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppressionXing Yang, Ryan Huang, Meng Fang, et al.
Hepatology (Baltimore, Md.)|July 10, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylationLiangjun Zhang, Pingfan Xie, Mingqiao Li, et al.
ACS Nano|August 20, 2025
Endogenous Targeting of Lipid Nanoparticles to Kidney TumorsAmogh Vaidya, Yun-Chieh Sung, Vanina Toffessi Tcheuyap, et al.
ACS Nano|December 30, 2022
Mo<sub>2</sub>TiC<sub>2</sub> MXene-Supported Ru Clusters for Efficient Photothermal Reverse Water-Gas ShiftZhiyi Wu, Jiahui Shen, Chaoran Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 RadioligandsDaniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Physical Review Letters|September 27, 2024
Dominant Charge Density Order in TaTe_{4}Hongtao Rong, Qiangqiang Gu, Xue Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA<sup>+</sup> Metastatic Colorectal CancersChengcheng Zhang, Zhe Wang, Zhi Yang, et al.
Pageof 56